612 related articles for article (PubMed ID: 34786565)
1. All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses.
Setaro AC; Gaglia MM
Curr Res Virol Sci; 2021; 2():100015. PubMed ID: 34786565
[TBL] [Abstract][Full Text] [Related]
2. Evasion of Type I Interferon by SARS-CoV-2.
Xia H; Cao Z; Xie X; Zhang X; Chen JY; Wang H; Menachery VD; Rajsbaum R; Shi PY
Cell Rep; 2020 Oct; 33(1):108234. PubMed ID: 32979938
[TBL] [Abstract][Full Text] [Related]
3. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus.
Devaraj SG; Wang N; Chen Z; Chen Z; Tseng M; Barretto N; Lin R; Peters CJ; Tseng CT; Baker SC; Li K
J Biol Chem; 2007 Nov; 282(44):32208-21. PubMed ID: 17761676
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.
Deng J; Zheng Y; Zheng SN; Nan ML; Han L; Zhang J; Jin Y; Pan JA; Gao C; Wang PH
J Med Virol; 2023 Mar; 95(3):e28561. PubMed ID: 36755358
[TBL] [Abstract][Full Text] [Related]
5. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
[TBL] [Abstract][Full Text] [Related]
7. Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner.
Ran XH; Zhu JW; Chen YY; Ni RZ; Mu D
Front Immunol; 2022; 13():947272. PubMed ID: 36032116
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
Moustaqil M; Ollivier E; Chiu HP; Van Tol S; Rudolffi-Soto P; Stevens C; Bhumkar A; Hunter DJB; Freiberg AN; Jacques D; Lee B; Sierecki E; Gambin Y
Emerg Microbes Infect; 2021 Dec; 10(1):178-195. PubMed ID: 33372854
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
10. Roles and functions of SARS-CoV-2 proteins in host immune evasion.
Rashid F; Xie Z; Suleman M; Shah A; Khan S; Luo S
Front Immunol; 2022; 13():940756. PubMed ID: 36003396
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
[TBL] [Abstract][Full Text] [Related]
12. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
Zheng Y; Zhuang MW; Han L; Zhang J; Nan ML; Zhan P; Kang D; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2020 Dec; 5(1):299. PubMed ID: 33372174
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
Shemesh M; Aktepe TE; Deerain JM; McAuley JL; Audsley MD; David CT; Purcell DFJ; Urin V; Hartmann R; Moseley GW; Mackenzie JM; Schreiber G; Harari D
PLoS Pathog; 2021 Aug; 17(8):e1009800. PubMed ID: 34437657
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
Oh SJ; Shin OS
Cells; 2021 Mar; 10(3):. PubMed ID: 33801464
[TBL] [Abstract][Full Text] [Related]
15. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.
Li JY; Liao CH; Wang Q; Tan YJ; Luo R; Qiu Y; Ge XY
Virus Res; 2020 Sep; 286():198074. PubMed ID: 32589897
[TBL] [Abstract][Full Text] [Related]
16. Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion.
Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746745
[TBL] [Abstract][Full Text] [Related]
17. An anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon induction.
Yamaguchi M; Kitagawa Y; Zhou M; Itoh M; Gotoh B
FEBS Lett; 2014 Jan; 588(1):28-34. PubMed ID: 24269682
[TBL] [Abstract][Full Text] [Related]
18. Activation and evasion of type I interferon responses by SARS-CoV-2.
Lei X; Dong X; Ma R; Wang W; Xiao X; Tian Z; Wang C; Wang Y; Li L; Ren L; Guo F; Zhao Z; Zhou Z; Xiang Z; Wang J
Nat Commun; 2020 Jul; 11(1):3810. PubMed ID: 32733001
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
Chen J; Li Z; Guo J; Xu S; Zhou J; Chen Q; Tong X; Wang D; Peng G; Fang L; Xiao S
J Virol; 2022 Apr; 96(8):e0003722. PubMed ID: 35389264
[TBL] [Abstract][Full Text] [Related]
20. Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism.
Huang SH; Lee TY; Lin YJ; Wan L; Lai CH; Lin CW
J Microbiol Immunol Infect; 2017 Jun; 50(3):277-285. PubMed ID: 26320399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
